Analysis of the key themes driving M&A activity reveals that health & wellness accounted for three pharmaceutical deals announced in Q3 2024, worth a total value of $110m. The $110m acquisition of Catholic Medical Center by HCA Healthcare was the industry’s largest disclosed deal. GlobalData’s Pharmaceuticals Industry Mergers and Acquisitions Deals by Top Themes report for Q3 2024 dissects the driving forces behind the M&A dynamics within the Pharma sector, offering essential insights into industry trends and transformations. Buy the report here.
In value terms, health & wellness-related deal activity increased by 400% in Q3 2024 compared with the previous quarter’s total of $22m and rose by 38% as compared to Q3 2023. Related deal volume decreased by 25% in Q3 2024 versus the previous quarter and was 40% lower than in Q3 2023.
The top-ranked financial advisors supporting these M&A deals in 9M 2024 were Chardan Capital Markets; Maxim Group; Mertz Taggart with 1, 1, 1 deals respectively.
The top-ranked legal advisors supporting these M&A deals in 9M 2024 were Fox Rothschild; Gibson, Dunn & Crutcher; Mintz, Levin, Cohn, Ferris, Glovsky and Popeo PC with 1, 1, 1 deals respectively.
For further understanding of GlobalData's Pharmaceuticals Industry M&A Deals by Top Themes in Q3 2024 – Strategic Intelligence, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.